These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
348 related items for PubMed ID: 16518538
21. Acyl-CoA binding protein (ACBP) regulates acyl-CoA:cholesterol acyltransferase (ACAT) in human mononuclear phagocytes. Kerkhoff C, Beuck M, Threige-Rasmussen J, Spener F, Knudsen J, Schmitz G. Biochim Biophys Acta; 1997 Jun 02; 1346(2):163-72. PubMed ID: 9219899 [Abstract] [Full Text] [Related]
22. Recombinant acyl-CoA:cholesterol acyltransferase-1 (ACAT-1) purified to essential homogeneity utilizes cholesterol in mixed micelles or in vesicles in a highly cooperative manner. Chang CC, Lee CY, Chang ET, Cruz JC, Levesque MC, Chang TY. J Biol Chem; 1998 Dec 25; 273(52):35132-41. PubMed ID: 9857049 [Abstract] [Full Text] [Related]
23. Chemical modification of acyl-CoA:cholesterol O-acyltransferase. 1. Identification of acyl-CoA:cholesterol O-acyltransferase subtypes by differential diethyl pyrocarbonate sensitivity. Kinnunen PM, DeMichele A, Lange LG. Biochemistry; 1988 Sep 20; 27(19):7344-50. PubMed ID: 3207680 [Abstract] [Full Text] [Related]
24. Protein phosphatase 1 and 2A inhibitors activate acyl-CoA:cholesterol acyltransferase and cholesterol ester formation in isolated rat hepatocytes. Hernández ML, Martínez MJ, López de Heredia M, Ochoa B. Biochim Biophys Acta; 1997 Nov 30; 1349(3):233-41. PubMed ID: 9434137 [Abstract] [Full Text] [Related]
25. A selective ACAT-1 inhibitor, K-604, suppresses fatty streak lesions in fat-fed hamsters without affecting plasma cholesterol levels. Ikenoya M, Yoshinaka Y, Kobayashi H, Kawamine K, Shibuya K, Sato F, Sawanobori K, Watanabe T, Miyazaki A. Atherosclerosis; 2007 Apr 30; 191(2):290-7. PubMed ID: 16820149 [Abstract] [Full Text] [Related]
26. Glabrol, an acyl-coenzyme A: cholesterol acyltransferase inhibitor from licorice roots. Choi JH, Rho MC, Lee SW, Kwon OE, Park HR, Kang JY, Lee SH, Lee HS, Bae KH, Kim YK. J Ethnopharmacol; 2007 Apr 04; 110(3):563-6. PubMed ID: 17123760 [Abstract] [Full Text] [Related]
27. Therapeutic potential of ACAT inhibitors as lipid lowering and anti-atherosclerotic agents. Sliskovic DR, White AD. Trends Pharmacol Sci; 1991 May 04; 12(5):194-9. PubMed ID: 1862535 [Abstract] [Full Text] [Related]
28. Selective ACAT inhibitors as promising antihyperlipidemic, antiathero-sclerotic and anti-Alzheimer drugs. Giovannoni MP, Piaz VD, Vergelli C, Barlocco D. Mini Rev Med Chem; 2003 Sep 04; 3(6):576-84. PubMed ID: 12871160 [Abstract] [Full Text] [Related]
29. ACBP and cholesterol differentially alter fatty acyl CoA utilization by microsomal ACAT. Chao H, Zhou M, McIntosh A, Schroeder F, Kier AB. J Lipid Res; 2003 Jan 04; 44(1):72-83. PubMed ID: 12518025 [Abstract] [Full Text] [Related]
30. Acyl-coenzyme A:cholesterol acyltransferase in human liver. In vitro detection and some characteristics of the enzyme. Erickson SK, Cooper AD. Metabolism; 1980 Oct 04; 29(10):991-6. PubMed ID: 7421586 [Abstract] [Full Text] [Related]
31. Design, synthesis and pharmacology of aortic-selective acyl-CoA: Cholesterol O-acyltransferase (ACAT/SOAT) inhibitors. Shibuya K, Kawamine K, Miura T, Ozaki C, Edano T, Mizuno K, Yoshinaka Y, Tsunenari Y. Bioorg Med Chem; 2018 Aug 07; 26(14):4001-4013. PubMed ID: 29945757 [Abstract] [Full Text] [Related]
32. Effect of E5324, a novel inhibitor of acyl-CoA:cholesterol acyltransferase, on cholesteryl ester synthesis and accumulation in macrophages. Kogushi M, Tanaka H, Kobayashi H, Yamada T, Ohtsuka I, Kimura T, Saito I. Jpn J Pharmacol; 1995 Jun 07; 68(2):191-9. PubMed ID: 7563976 [Abstract] [Full Text] [Related]
33. Hypolipidemic and antioxidant activity of the novel acyl-CoA:cholesterol acyltransferase (ACAT) inhibitor KY-455 in rabbits and hamsters. Nakamura S, Kamiya S, Shirahase H, Kanda M, Yoshimi A, Tarumi T, Kurahashi K. Arzneimittelforschung; 2004 Jun 07; 54(2):102-8. PubMed ID: 15038459 [Abstract] [Full Text] [Related]
34. Tomatidine, a tomato sapogenol, ameliorates hyperlipidemia and atherosclerosis in apoE-deficient mice by inhibiting acyl-CoA:cholesterol acyl-transferase (ACAT). Fujiwara Y, Kiyota N, Tsurushima K, Yoshitomi M, Horlad H, Ikeda T, Nohara T, Takeya M, Nagai R. J Agric Food Chem; 2012 Mar 14; 60(10):2472-9. PubMed ID: 22224814 [Abstract] [Full Text] [Related]
38. Rat liver acyl-coenzyme A:cholesterol acyltransferase: its regulation in vivo and some of its properties in vitro. Erickson SK, Shrewsbury MA, Brooks C, Meyer DJ. J Lipid Res; 1980 Sep 15; 21(7):930-41. PubMed ID: 7441061 [Abstract] [Full Text] [Related]
39. Protein synthesis inhibition in mouse peritoneal macrophages results in increased acyl coenzyme A:cholesterol acyl transferase activity and cholesteryl ester accumulation in the presence of native low density lipoprotein. Tabas I, Boykow GC. J Biol Chem; 1987 Sep 05; 262(25):12175-81. PubMed ID: 3624250 [Abstract] [Full Text] [Related]
40. beta-sitosterol: esterification by intestinal acylcoenzyme A: cholesterol acyltransferase (ACAT) and its effect on cholesterol esterification. Field FJ, Mathur SN. J Lipid Res; 1983 Apr 05; 24(4):409-17. PubMed ID: 6854150 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]